Michael Catelani - Jan 3, 2023 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
President, COO & CFO
Signature
/s/ Michael J. Catelani
Stock symbol
ANIX
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 07:53 PM
Previous filing
Nov 1, 2022
Next filing
May 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +350K $0.00 350K Jan 3, 2023 Common Stock 350K $4.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023.